| Name | amcasertib |
|---|---|
| Synonyms |
N-[2-(Diethylamino)ethyl]-2,4-dimethyl-5-{(Z)-[2-oxo-5-(2-phenyl-1,3-thiazol-4-yl)-1,2-dihydro-3H-indol-3-ylidene]methyl}-1H-pyrrole-3-carboxamide
BBI503 amcasertib 1H-Pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[(Z)-[1,2-dihydro-2-oxo-5-(2-phenyl-4-thiazolyl)-3H-indol-3-ylidene]methyl]-2,4-dimethyl- UNII:GLY8ABW25V |
| Description | Amcasertib is an orally administered investigational agent designed to inhibit cancer stem cell pathways, including Nanog, by targeting stemness kinases. |
|---|---|
| Related Catalog |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Molecular Formula | C31H33N5O2S |
| Molecular Weight | 539.691 |
| Exact Mass | 539.235474 |
| LogP | 5.72 |
| Index of Refraction | 1.651 |
| Storage condition | -20℃ |